Blog - Page 3186 of 5440

ThursdayJun 23, 2011 4:33 pm

CorMedix, Inc. (CRMD) Notes Latest FDA Correspondence regarding Neutrolin®

CorMedix, Inc., a pharmaceutical company focused on developing and commercializing therapeutic products to prevent and treat cardiorenal disease, today detailed its latest correspondence from the U.S. Food and Drug Administration (FDA) regarding the company’s regulatory submission for Neutrolin®. Neutrolin is the CorMedix’s candidate for the prevention of catheter-related bloodstream infections. The company recently filed a Request for Designation (RFD), which allows the FDA to determine the product type and assign the product to the appropriate lead center. In its filing, CorMedix proposed for Neutrolin to be classified as a device and assigned to the Center For Devices and Radiological Health…

ThursdayJun 23, 2011 3:22 pm

Columbia Clean Power & Fuels Inc. (CCPF) Completes and Announces Results of Feasibility Study of Coking Production Facility

Columbia Clean Power & Fuels, Inc., a company that engages in coal mining, coal coking, and clean coal technology operations in the Republic of Columbia, recently announced that it has received the complete results of a feasibility study that has been prepared by Hong Kong Dongshi Coal Chemistry Engineering Consultancy & Management Co. Ltd. for the Company’s planned 200,000 tons-per-year coking production facility. This facility is a part of the Company’s strategy to provide for market-ready high-grade coke to the global industry of steel, in addition to the mining and sale of metallurgical coal in its first phase of development…

ThursdayJun 23, 2011 3:11 pm

FluoroPharma Medical, Inc. (FPMI) Announces $1.6M Capital Raise

FluoroPharma Medical announced it has received subscriptions from select accredited investors for gross proceeds of $1.6 million in a private placement offering. The proceeds from this financing together with the previously announced financing in May 2011 aggregates $5.3 million. The Company intends to use the proceeds of the offering for working capital purposes. "We are pleased that we can continue to fund the advancement of our portfolio of compounds," said Thijs Spoor, FluoroPharma's Chief Executive Officer. "This step will allow the company to significantly advance its clinical development." Dr. David Elmaleh, Chairman of the Board of Directors and the inventor…

ThursdayJun 23, 2011 11:05 am

Cross Border Resources, Inc. (XBOR) Updates 2011 Oil and Gas Budget

Cross Border Resources, Inc. released updated details on the company’s oil and gas exploration and development program for the third and fourth quarters of 2011. Cross Border Resources has budgeted $7.4 million in capital expenditures for the second half of 2011, compared to $1.0 million in the first half of the year. The acceleration in spending is due to increased interest and funding from working interest partners on the company’s Permian Basin properties. Cross Border Resources said that these additional funds will allow the company to spud 21 gross wells over the next six months, bringing the total drilling program…

ThursdayJun 23, 2011 11:04 am

Beacon Enterprise Solutions Group, Inc. (BEAC) Announces $1.2M in New Engagements with Existing Clients, Anticipates Massive Project Snowballing

Beacon Enterprise Solutions Group, prized for their comprehensive solutions to the ever-changing demands of today’s high performance Information Technology Systems (ITS) infrastructures, reported the request of new ITS infrastructure engagements from two of the Company’s existing Fortune 100 clients, engagements which represent some $1.2M in revenue. One of BEAC’s top pharmaceutical clients, a Fortune 500 company with whom Beacon has continued to win multiple incremental ITS projects, learning the facilities inside and out and becoming the client’s de facto standard so as to ensure compliance, is the first engagement. This first engagement is expected to bring in some $900k in…

ThursdayJun 23, 2011 11:02 am

PURE Bioscience, Inc. (PURE) Receives Canadian Approval for Hard Surface Disinfectant

PURE Bioscience, Inc. is the developer of the patented silver dihydrogen citrate (SDC) antimicrobial disinfectant. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. U.S. EPA-registered PURE Hard Surface provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial kill times and 24-hour residual protection. It completely kills resistant pathogens like MRSA and also effectively eliminates dangerous fungi and viruses including HIV, Norovirus, Influenza A, Avian Influenza and H1NI. PURE Hard Surface is EPA-registered for use…

ThursdayJun 23, 2011 11:01 am

NovaGold Resources, Inc. (NG) Moves Forward on Galore Creek, Major Copper-Gold-Silver Property

NovaGold, a precious metals exploration and development company focused on British Columbia and Alaska, has announced significant progress towards completion of a pre-feasibility study for its Galore Creek copper-gold-silver project in British Columbia. The study is expected to be complete by July, and a National Instrument 43-101 compliant technical report is concurrently being prepared by AMEC Americas Limited. The Galore Creek property covers nearly 460 square miles in northwestern British Columbia, and is owned equally by subsidiaries of NovaGold and Teck Resources. It represents one of the world’s largest undeveloped copper-gold-silver deposits. NovaGold President and CEO, Rick Van Nieuwenhuyse, said…

ThursdayJun 23, 2011 10:31 am

Uranium Energy Corp. (UEC) Video Chart for Thursday, June 23, 2011

UEC is holding a higher low and making a nice, rounded bottom at this point. The indicators are holding bullish positions as the price per share is now right against a resistance point and threatening to breakout. The next strong area of resistance doesn't come into play until $3.75. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

ThursdayJun 23, 2011 8:22 am

Cono Italiano, Inc. (CNOZ) Issues Shareholder Letter to Investors

Cono Italiano, Inc., which holds the exclusive license for the North American Distribution and Manufacturing rights for "Pizza Cono," a one-of-a-kind, drip-free, cone shaped pizza made from proprietary dough and manufacturer of frozen foods, today provided a broad overview to answer various inquiries from shareholders concerning the company's current position and the direction headed. 1. Where is CNOZ headed at this time and where are our efforts being focused? We are in the final stages of completing a USDA and FDA approved production facility with our manufacturing partner. This facility will afford us the opportunity to be the sole manufacturer…

ThursdayJun 23, 2011 7:56 am

Focus Gold Corp. (FGLD) Further Expands Holdings in Historic Mining Municipality in Mexico

Yesterday, Focus Gold Corp. announced that the Company further expanded their holdings in the historic mining municipality of Compostela, Nayarit State, Mexico. They accomplished this by acquiring an additional claim totaling approximately 2,367 hectares (Focus 3). Focus 3 borders to the south of Focus Gold Corp.'s previously acquired Focus 1 Claim. With this acquisition, the Company's land holdings in Nayarit now exceed 31,000 hectares in total, with most of it contiguous. Their Focus 1 claim surrounds the Huicicila Project to the north and east. Focus 1 is adjacent on the east to the caldera containing Cream Minerals' 2560-Hectare Nuevo Milenio…

Site Search

Company Search